Pulmonx Corp Research And Development Expense

• Pulmonx Corp showed an increase of +10.9% in Research And Development Expense from 2024 to 2025.
• This data is from Pulmonx Corp's annual report (Form 10-K), filed with the SEC on March 10, 2026.
• XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2018 to 2025), Pulmonx Corp's Research And Development Expense has grown by 178.8%.
• Historical annual values: Fiscal year 2025: $19.49 million | Fiscal year 2024: $17.57 million | Fiscal year 2023: $18.08 million | Fiscal year 2022: $15.40 million | Fiscal year 2021: $13.06 million | Fiscal year 2020: $7.46 million | Fiscal year 2019: $6.05 million | Fiscal year 2018: $6.99 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026